ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
13.06
+2.11 (19.27%)
At close: Jan 9, 2026, 4:00 PM EST
13.00
-0.06 (-0.47%)
After-hours: Jan 9, 2026, 7:59 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.29 billion as of January 9, 2026. Its market cap has increased by 18.60% in one year.
Market Cap
1.29B
Enterprise Value
1.17B
1-Year Change
18.60%
Ranking
Category
Stock Price
$13.06
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.29B, an increase of 127.18%. That is a compound annual growth rate of 29.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.29B | 12.10% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |